Equity Overview
Price & Market Data
Price: $170.8
Daily Change: -$0.12 / 0.07%
Range: $169.7 - $173.8
Market Cap: $10,332,409,856
Volume: 265,613
Performance Metrics
1 Week: -1.31%
1 Month: 8.65%
3 Months: 11.65%
6 Months: 31.72%
1 Year: 29.46%
YTD: 24.06%
Details
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.